Qualigen Therapeutics Inc (QLGN) stock is down -32.31% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives QLGN stock a score of 8 out of a possible 100.
That rank is chiefly influenced by a fundamental score of 0. QLGN stock has a mean target price of 10. This means analysts expect the stock to gain 184.09% over the next 12 months. QLGN's rank also includes a long-term technical score of 7. The short-term technical score for QLGN is 15.
What's Happening with QLGN Stock Today
Qualigen Therapeutics Inc (QLGN) stock is down -0.58% while the S&P 500 is down -2.53% as of 3:25 PM on Wednesday, Jan 27. QLGN is down -$0.02 from the previous closing price of $3.54 on volume of 6,909,572 shares. Over the past year the S&P 500 has risen 14.53% while QLGN is down -32.31%. QLGN lost -$4.68 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Qualigen Therapeutics Inc (QLGN) Stock.
